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Introduction: Aeromonas veronii biovar sobria is a rare cause of bacteremia, with several studies indicating that this
isolate may be of particular clinical significance since it is enterotoxin producing. A wide spectrum of infections has
been associated with Aeromonas species in developing countries that include gastroenteritis, wound infections,
septicemia and lung infections. This infection, caused by Aeromonas species, is usually more severe in
immunocompromised than immunocompetent individuals. We here describe a case of soft tissue infection and
severe sepsis due to Aeromonas sobria in an immunocompromised patient.
Case presentation: A 74-year-old Caucasian man with a clinical history of chronic lymphocytic leukemia and
immune thrombocytopenia, periodically treated with steroids, was admitted to our Intensive Care Unit because of
necrotizing fasciitis and multiorgan failure due to Aeromonas sobria, which resulted in his death. The unfortunate
coexistence of a Candida albicans infection played a key role in the clinical course.
Conclusion: Our experience suggests that early recognition and aggressive medical and surgical therapy are
determinants in the treatment of severe septicemia caused by an Aeromonas sobria in an immunocompromised
patient.
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Necrotizing fasciitis is a destructive soft tissue infection
characterized by an extensive necrosis in skin, subcuta-
neous tissues and fascia that is associated with systemic
toxicity and fulminant course with a mortality rate va-
rying from 40% to 60% [1]. Immunosuppression, dia-
betes mellitus, alcoholism, end-stage renal disease,
malignancy and chemotherapy have all been suggested
as predisposing factors in necrotizing fasciitis [2].
Bacteria associated with necrotizing fasciitis include
Aeromonas species [3]. Aeromonas organisms are
Gram-negative small bacilli isolated from a variety of
environmental sources including water, seafood, meat
and vegetables, with the ability to colonize both humans
and animals [4]. The clinical spectrum of Aeromonas* Correspondence: savinospadaro@gmail.com
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unless otherwise stated.species infection in humans includes acute gastroenter-
itis, hepatobiliary tract infection, pneumonia, empyema,
meningitis, septic arthritis, osteomyelitis, endocarditis,
bacteremia, burn and wound infection [5,6].
Clinical isolates in 85% of human infections involve
three phenotypically defined species: Aeromonas hydro-
phila, Aeromonas caviae and Aeromonas veronii biovar
sobria [7]. A. veronii biovar sobria is predominantly
isolated in patient’s blood and is more pathogenic than
A. hydrophila [7,8]. The possible portals of entry for Aero-
monas bacteremia are gastrointestinal tracts, skin lesions,
previous surgery or local trauma in an aqueous environ-
ment [9]. After adhesion to epithelial cells, Aeromonas
produces many virulent factors which destroy host epi-
thelial barriers and impair immune cells, including exoen-
zymes, cytotoxic and cytotonic enterotoxins, hemolysins,
proteinases, lipases, agglutinins, various hydrolytic enzymes,
translocation capacity and a Aeromonas sobria cytotoxicl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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healthy and trauma patients, but immunocompromised
hosts with hematologic malignancy, cancer and hepato-
biliary diseases are considered to be at greatest risk [12].
Patients with severe wound infection (myonecrosis)
caused by this microorganism also develop sepsis, and
90% of patients succumb to their infections [13]. The
fatality rate of Aeromonas soft tissue infections and
bacteremia is high and reportedly ranges from as much as
28% to 73%, with septic shock being the cause of death in
the majority of patients [14].
Case presentation
We present the case of a 74-year-old Caucasian man with
a medical history of ischemic heart disease, atrial flutter, ar-
terial hypertension, severe aortic stenosis, chronic lympho-
cytic leukemia and related immune thrombocytopenia
periodically treated with steroids (every 28 days). He was
referred to our Emergency Room for fever and an altered
state of consciousness. During the clinical examination,
his temperature was 40°C, his blood pressure was 120/
80mmHg, pulse 89 beats per minute, arrhythmic and his
initial oxygen saturation checked by pulse oximetry was
95% in room air. He was somnolent but easily aroused
and on examination presented pulmonary bibasal crepita-
tions, heart murmur and a hematoma on his left foot. A
laboratory evaluation revealed an increase in white blood
cell (WBC) count (15.0×103/μL; reference value 4.00 to
11.00×103/μL), platelet count of 56×103 cells/μL (refer-
ence value 150 to 450×103 cells/μL), and C-reactive pro-
tein 6.6mg/dL (reference value 0.0 to 0.5mg/dL). Four
days before hospital admission, while fishing, his left hand
had been scratched by the dorsal fin spine of a black bull-
head (Ameiurus melas, catfish); no physical signs in situ
were present on initial examination. He was hospitalized
in the Clinic of Infectious Diseases, Ferrara. On admission,
an empiric antibiotic treatment with ampicillin-sulbactam
(3g every 8 hours, intravenous) was initiated intra-
venously; blood cultures were performed. The day after
admission, his vital signs and body temperature were nor-
mal but he began to complain of muscle weakness and of
severe pain in his lower extremities, radiating to his knees.
A neurological examination revealed an asymmetric
hyposthenia and hypoesthesia of his lower limbs, bilateral
areflexia of his Achilles tendon, lower extremity acute
paresis, and bladder dysfunction. A spine magnetic reson-
ance imaging excluded cauda equina syndrome, while the
vascular surgeon excluded an acute ischemic peripheral
event. To exclude endocarditis an echocardiography was
performed, revealing a global cardiac contractile dysfunc-
tion with a severe reduction in ejection fraction (35%).
Antibiotic therapy was changed to ceftriaxone (2g every
24 hours, intravenous) and levofloxacin (500mg every 12
hours, intravenous) because of the further increase in hisWBC count (24.3×103 cells/mm3), and blood cultures re-
vealed an increase in Gram-negative bacilli that were later
confirmed to be A. sobria, the latter being identified by
Vitek® II method.
After 48 hours, his clinical condition deteriorated and
he developed severe sepsis with hypotension (systolic
blood pressure was 80mmHg) and peripheral vasocon-
striction, acute renal failure with oliguria (urea: 159mg/dL
and creatinine: 2.55mg/dL), and severe metabolic acidosis.
He was therefore transferred to our Intensive Care Unit
(ICU). At this time, laboratory values were as follows:
WBC count of 17.4×103 cells/mm3, platelet count of
38×103 cells/mm3, procalcitonin 99.3ng/mL (reference
value <0.05ng/mL), and C-reactive protein 46.9mg/dL
(reference value 0 to 0.5mg/dL). An antimicrobial regimen
was promptly implemented with meropenem (1g every 12
hours, intravenous) and linezolid (600mg every 12 hours,
intravenous). Laboratory data suggested a diagnosis of
rhabdomyolysis (creatinine phosphinase 5013U/L; refer-
ence value <190U/L), myoglobinemia 13270ng/mL (refer-
ence value 28 to 72ng/mL), lactate dehydrogenase 673U/L
(reference value 240 to 480U/L) and, on physical examina-
tion, his lower limbs were warm in presence of erythema.
After 12 hours, the swelling of his legs and progression of
skin lesions (circumferential erythema developed in bullae
formations) increased until a compartment syndrome de-
veloped, rapidly requiring surgical treatment with bilateral
fasciotomy (Figures 1 and 2).
Blood culture results were available 3 days after ICU ad-
mission. The strain was identified as Aeromonas sobria.
The isolate was susceptible to amikacin, cefepime, cefo-
taxime, ceftazidime, levofloxacin, ertapenem, gentamicin,
and piperacillin-tazobactam. Resistance to meropenem
and imipenem were also observed. Antibiotics were ad-
justed in relation to blood culture and sensitivities. Conse-
quently, meropenem was discontinued and he was given
ceftazidime (2g every 8 hours, intravenous).
On ICU day 7, due to return of spiking fever and leg
pain, computed tomography (CT) scans were performed.
CT scans of his lower extremities showed progression to
overt fasciitis with gaseous infiltration in the soft tissues
(Figure 3). In view of the CT scan images and microbio-
logical results, the surgeon was consulted and amputation
for necrotizing infections of the extremities was per-
formed. Deep wound cultures yielded growth of Gram-
negative bacilli, which were identified as A. sobria. No
anaerobes were detected from necrotic tissue. After sur-
gical and medical treatment, his clinical status showed
progressive improvement in renal, cardiocirculatory,
splanchnic and metabolic function. Laboratory findings
revealed no further signs of rhabdomyolysis (creatinine
phosphinase 97U/L, lactate dehydrogenase 378U/L); a
progressive reduction in WBC count (13.7×103 cells/mm3),
a platelet count of 122×103 cells/mm3, procalcitonin
Figure 1 Early skin lesions of lower limbs before fasciotomy.
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observed. Over the course of weeks, consecutive blood
cultures showed Aeromonas microorganisms were no
longer isolated.
Although surgical wounds following bilateral amputa-
tion presented no further signs of necrosis, frequent sur-
gical debridements were still necessary. In order to
perform these painful procedures he was heavily sedated
and required mechanical ventilation, which prolonged
his stay in the ICU. Despite the aggressive treatment and
administration of broad-spectrum antibiotics, including
antifungal prophylaxis, the coexistence of immuno-
compromised host and comorbidities induced during his
ICU stay, caused the development of an invasive candi-
demia (Candida albicans) which was ultimately respon-
sible for his death.
Discussion
The clinical manifestations and outcomes of Aeromonas-
associated soft tissue infections vary in relation to theFigure 2 Gangrenous lower limbs after fasciotomy.immune status of the host. Since Aeromonas species
were considered rare pathogens of necrotizing fasciitis
in immunocompromised patients [11,12], we present an
uncommon case of A. sobria necrotizing fasciitis in Italy.
In immunocompromised hosts, Aeromonas-associated
soft tissue infections can be fulminant and fatal. Previous
studies have shown that Aeromonas species infec-
tions are strongly associated with mortality [15]. Table 1
shows cases of Aeromonas species necrotizing fasciitis
that have been reported in the literature. Similar features
are revealed in the literature and previously described
case reports have comparable clinical characteristics.
Chang et al. [6] illustrated a fulminant necrotizing fas-
ciitis caused by A. sobria in patients with neutropenia
whose fatal clinical course was just like that described by
Martino et al. [9] in their report of two cases with acute
non-lymphoblastic leukemia who developed septic shock
caused by Aeromonas species with soft tissue compli-
cations. Both studies confirm the potentially aggressive
nature of these bacteria in patients with neutropenic
Figure 3 Computed tomography scans of legs demonstrating gas gangrene.
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skin necrosis and sepsis caused by A. sobria in two
patients with diabetes who died only a few days after
admission. Finally, Stano et al. [4] described a fatal A.
sobria sepsis complicated by rhabdomyolysis in a patient
with human immunodeficiency virus. What is described
in the literature seems to suggest that A. sobria is the
more pathogenic among Aeromonas bacteria since only
patients with infections caused by A. hydrophila sur-
vived [9].
Two mechanisms have been proposed to explain the on-
set of Aeromonas soft tissue skin infection. The first
mechanism postulates that the bacterium invades through
trauma, triggering primary infection of the soft tissue
causing subsequent development of sepsis. According to
the second mechanism, sepsis is first induced by the
pathogen and then by metastatic lesions in the soft tissue
[11]. In patients with bacteremia, the source of bacteremia
is often unclear. A review reported that Aeromonas spe-
cies are causative organisms more commonly found in
those who are exposed to seawater or raw seafood, making
fisherman an occupation group at higher risk [3].
The ability of Aeromonas to cause disease is affected not
only by patient characteristics but also microbial factors,
and the products of the organisms are responsible for
hypotension, multiorgan failure, and disseminated intra-
vascular coagulation, which may lead to septic shock as a
result of vascular leakage and vasodilatation [3].
A. sobria is a human pathogen; the cases of bacterial
infections described refer to healthy subjects affected
with gastrointestinal infection [10]. However, patients
with severe wound infection caused by A. sobria also de-
velop sepsis and >90% of the patients succumb to their
infections; published data have shown that a serine pro-
teinase secreted by A. sobria, at infection sites or in the
circulation, points to a mechanism of virulence that
could be associated with the induction of septic shock
caused by infection with this bacterium [10].
Although Aeromonas has a propensity to produce at
least three β-lactamases, these microorganisms are gen-
erally susceptible to the majority of antibiotics activeagainst Gram-negative bacilli. This notwithstanding,
increasing antimicrobial resistance among Aeromonas
species has been observed depending mainly on species,
source and country of isolation [4,5]. Some authors
recommend obtaining a susceptibility test before decid-
ing the correct treatment regime and delaying proper
antibiotics until culture results are available. This delay,
however, may endanger patients, especially neutropenic
patients [4,6]. After evaluating monomicrobial Aeromonas,
Ko and Chuang did not observe any major differences in
treatment with a combination of aminoglycoside and
β-lactam, and they suggested that a broad-spectrum
cephalosporin remains one of the main therapeutic
choices in invasive Aeromonas infections [5].
The two most common pitfalls in management of
Aeromonas necrotizing fasciitis are the failure to make
an early diagnosis and inadequate medical and surgical
treatment [6]. The literature reports that early surgical
intervention is essential in immunocompromised hosts
with this infection [9] and that more aggressive early
surgical intervention may be indicated in these patients
[14].
In the present case, all predisposing factors for a
typical Aeromonas infection were present; our patient
had a clinical history of hematological disorders and in-
fection was most likely caused by exposure of a wound
to contaminated water (the patient had immersed his
hands into potentially contaminated water while fishing
and was scratched by a catfish). Nevertheless, some as-
pects contributed to failure of the case. The lack of any
clear clinical signs and symptoms prevented early diag-
nosis. It is crucial to remember that pain which appears
to be disproportional to the physical findings is the most
consistent manifestation of necrotizing fasciitis, and that
the presence of bullae also constitutes an important
diagnostic clue. It is suggested in the literature that these
two aspects should be taken into account since the
earlier necrotizing fasciitis is diagnosed, the better the
outcome and the fewer the complications [12]. During
the first 36 hours spent in our Medical Department, our
patient mainly presented pain and motor disability,
Table 1 Cases of necrotizing fasciitis caused by Aeromonas species reported in the medical literature
Cases Gender/
age (year)
Predisposing factors Location Species Antibiotics Surgical treatments Outcome/length
of stay (days)







F/39 T-lineage acute lymphoblastic
leukemia
Lower extremities A. sobria Imipenem/
cilastatin→levofloxacin
None Death/3
M/65 Acute myeloid leukemia Lower extremities A. sobria Ceftazidime+teicoplanin None Death/5
Tsai et al. [14] M/66 Diabetes mellitus, local
wound trauma
Forearm A. sobria Cefuroxime+gentamicin Fasciotomy+debridement Death/2





Stano et al. [4] M/43 Human immunodeficiency














M/50 Acute non-lymphoblastic leukemia Lower extremities A. sobria Ceftazidime+amikacin None Death/3
Kao et al. [16] M/76 Local trauma Hand Aeromonas
schubertii
Penicillin→minocycline Fasciotomy+debridement Death/-
Furusu et al. [17] M/66 Diabetes mellitus, liver dysfunction,
hemodialysed

















M/81 Congestive heart failure and
peripheral neuropathy
Forearm A. hydrophila Clindamycin+
Levofloxacin
Amputation Death/-
Kumar et al. [19] M/71 Hypertension and previous
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rect diagnosis.
Furthermore, clinical differentiation between Aeromonas
necrotizing fasciitis and infections caused by other micro-
organisms is no easy matter. In the case of gas-producing
muscular necrosis, as in our patient, an infection of
possible Clostridium origin should be taken into con-
sideration [15]. In the case of lesions where neither Gram-
positive nor anaerobic bacilli are detected, Aeromonas
ought to be suspected, just as the need to deliver prompt
and appropriate empiric antibiotic therapy and aggressive
surgical treatment should be considered. Concurrent
immunosuppression, consequent to the hematologic
disease and the chronic use of steroids may, in our case,
have contributed to the pathogenesis and virulence of the
Aeromonas disease, as well as the unfortunate coexistence
of fungal infection which played a key role in the clinical
course.Conclusions
This is a report of an uncommon case of Aeromonas
sobria sepsis in an immunocompromised patient. We
reviewed the literature and found that the presentation,
treatment and final resolution of this case is consistent
with the data presented in the literature.
It is, therefore, important for physicians caring for im-
munocompromised patients with necrotizing fasciitis to
consider the possible involvement of Aeromonas species
as the causative agent of infection. Time is a critical ele-
ment in the treatment of immunocompromised patients
presenting a rapid onset of skin necrosis and progressive
sepsis. Early recognition and aggressive medical and surgi-
cal therapy are the primary determinants of outcome in
the treatment of these patients.Consent
Informed written consent was obtained from the patient’s
next of kin for publication of this case report and any ac-
companying images. A copy of the written consent is
available for review by the Editor-in-Chief of this journal.
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